approval · primary record
NEDOSIRAN SODIUM
FDA · NDA · 2025-03-27
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-03-27 |
| Brand | RIVFLOZA |
| Sponsor | NOVO |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:39.145Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:NEDOSIRAN SODIUM:2025-03-27
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.